Table 1.
Group A |
Group B |
||||
---|---|---|---|---|---|
Left side | Control side | Left side | Control side | ||
Neural electrophysiological testing (mV) | Before transection | 0.68 ± 0.11 | 1.21 ± 0.13** | 0.75 ± 0.10 | 1.30 ± 0.09** |
After transection | 0.60 ± 0.08 | 0.67 ± 0.05 | |||
Bladder pressure (cmH2O) | Before transection | 10.20 ± 1.33 | 19.38 ± 1.02* | 10.91 ± 1.22 | 18.67 ± 1.12* |
After transection | 9.18 ± 1.22 | 10.00 ± 1.12 | |||
Qmax (ml/second) | Before transection | 15.30 ± 2.03 | 23.49 ± 3.16* | 14.78 ± 1.06 | 21.68 ± 3.19* |
After transection | 13.20 ± 1.63 | 13.77 ± 0.98 | |||
Residual urine volume (ml) | Before transection | 21.00 ± 5.09 | 9.57 ± 3.26* | 20.67 ± 4.18 | 11.00 ± 1.79* |
After transection | 23.14 ± 5.67 | 22.50 ± 3.83 |
*P < 0.05 vs. left side before and after the spinal lower motor neuron lesion. **P < 0.01 vs. left side before and after the spinal lower motor neuron lesion. In the measurement of bladder pressure, Qmax, and residual urine volume.